FOSTER CITY, Calif. and DURHAM, N.C. — 1Cell.Ai, a global leader in single cell precision diagnostics, has joined forces with BioSkryb Genomics, a pioneer in single cell multi-omics, to co-develop and commercialize next-generation single cell multi-omic solutions. This collaboration will empower researchers and clinicians to detect and characterize rare mutations in single cells with unprecedented accuracy, facilitating breakthroughs in cancer […]

Adds to robust offering of NGS tools enabling exome sequencing, whole genome sequencing, RNA sequencing, deep sequencing for liquid biopsy research and MRD, and methylation detection Diverse portfolio of adapter sets now includes industry leading number of unique indexes at 3,072 HT UDI Adapters Enables multiplexing and high throughput sequencing SOUTH SAN FRANCISCO, Calif. —  […]

Boulder, CO – Watchmaker Genomics, a leader in high-performance genomics solutions, today announced an important milestone in providing comprehensive and robust automated solutions for next-generation sequencing (NGS) workflows. Its collaboration with Revvity has resulted in fully automated and verified methods for all of its DNA and RNA library preparation kits on the Sciclone™ G3 NGSx* liquid […]

SINGAPORE — GenScript Biotech Corporation, a global leader in biotechnology research services, and NSG Bio, Singapore’s premier biotech incubator, today announced a strategic partnership designed to accelerate innovation and growth within the biotechnology sector. Through this partnership, GenScript will provide exclusive preferential rates along with technical guidance from experienced scientists across its extensive range of biotechnology services and […]

SCOTTS VALLEY, Calif. — Dovetail Genomics, a leading innovator in genomic solutions, today announced an expanded comprehensive analysis solution for somatic variation detection, addressing the challenge of identifying structural variants (SVs) using NGS platforms. The solution offers ultra-sensitive discovery of SVs at base-pair resolution down to 1% variant allele frequency (VAF), and biologically meaningful interpretation of SVs […]

Joint grant program will provide researchers focused on emerging areas of oncology with powerful multi-omic platforms to drive new discoveries DURHAM, N.C. & FREMONT, Calif. — BioSkryb Genomics, a pioneer in single-cell and ultra–low-input multi-omic solutions, and Ultima Genomics, a leader in scalable and cost-effective sequencing, today announced a collaboration designed to accelerate next-generation oncology research. […]

Forms Special Committee of the Board to Lead Evaluation of Viable Options for Maximizing Shareholder Value Engages Independent Financial and Legal Advisors to Support Thorough Process Remains Committed to Maintaining Focus on Cost Containment, Cash Preservation and Near-Term Initiatives to Enhance Value Farmingdale, NY — Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today […]

The Board of Directors of Biotage has concluded to recommend that the shareholders of Biotage accept the public offer from RWK BidCo, based on the assessment outlined below. Background This statement is made by the Board of Directors of Biotage AB (publ) (“Biotage” or the “Company”) (the “Board”) pursuant to section II.19 of the Nasdaq […]

New xGen™ hybridization and wash offering is poised to revolutionize targeted next generation sequencing workflows   CORALVILLE, Iowa – Ahead of the American Association for Cancer Research (AACR) 2025 Annual Meeting, global genomics solutions leader Integrated DNA Technologies (IDT) unveiled its xGen Hybridization and Wash v3 Kit, a newly designed target enrichment solution. The user-friendly workflow enables […]

REHOVOT, Israel — Sequentify is offering research grants to accelerate high-impact genomic studies through its uniquely fast, easy-to-use, and scalable targeted library preparation technology. Designed to enable the widespread adoption of high-throughput genomic testing, Sequentify’s protocol is ideal for large-scale programs conducting targeted sequencing at the population or cohort level. We invite proposals from research […]